PRACTICAL AND CLINICAL INSIGHT INTO TODAY'S GENERAL DERMATOLOGY ISSUES

Focus On: Formaldehyde Resin Finishing
Allergen Focus:
Focus On: Formaldehyde Resin Finishing

- W. Elliot Love, D.O., and Susan Nedorost, M.D.


 

In 1997, the Food and Drug Administration gave indication to the Thin-layer Rapid-Use Epicutaneous (T.R.U.E.) test for use as a valuable, first-line screening tool in the diagnosis of allergic contact dermatitis (ACD). Many dermatologists and allergists use this standard tool (see Table 1) in their practices and refer to contact dermatitis referral centers when the T.R.U.E test fails to identify a relevant allergen. Specifically, the T.R.U.E. test (panels 1.1 and 2.1) screens for 46 distinct allergens in addition to the Balsam of Peru mixture, and is thought to adequately identify an allergen in approximately 24.5% of patients.1


Recently, panel 3.1 has become available with five new allergens, including two new formaldehyde-releasing preservatives (diazolidinyl urea [Germall II] and imidazolidinyl urea [Germall]). This being said, many relevant allergens are not detected by use of this screening tool alone and, for this reason, “Allergen Focus” has been expanded to cover the notorious Allergens of the Year and other top relevant allergens identified by the North American Contact Dermatitis Group. This issue discusses dimethyloldihydroxyethylene urea (DMDHEU) and related cross-linking agents, additives that are used to make textiles wrinkle- and stain-resistant, among other things.

Contact Dermatides

The contact dermatides include allergic contact dermatitis (ACD), irritant contact dermatitis (ICD), and contact urticaria (CU). Irritant contact dermatitis is the most common form, accounting for approximately 80% of environmental-occupational based dermatoses. Contact urticaria (wheal and flare reaction) represents an IgE and mast cell-mediated immediate-type hypersensitivity reaction that can lead to anaphylaxis. The foremost example of this would be latex protein hypersensitivity. While this is beyond the scope of this section, we acknowledge this form of hypersensitivity due to the severity of the potential reactions and direct the reader to key resources.2,3

Allergic contact dermatitis is a T-cell-dependent delayed-type (Type IV) hypersensitivity reaction that has a high impact both in terms of patient morbidity and economics. This type of hypersensitivity reaction is primarily instigated by small lipophilic chemicals (haptens) with a molecular weight less than 500 Daltons. These chemical allergens trigger a complex immunologic cascade in the skin that leads to the clinical picture of ACD.

Case Illustration

A 51-year-old woman presented to the University Case Medical Center Contact Dermatitis Clinic with a
1-year history of pruritic vesicles on her volar fingertips and well demarcated erythematous pruritic scaly papules and plaques on her forearms. She worked as a dialysis technician, and her dermatitis almost completely cleared during a 2-week vacation. Use of gloves and a water-resistant laboratory coat improved her hand dermatitis, but the dermatitis on her forearms worsened. Of note, there was a sharp cut-off of the dermatitis at the edge of her T-shirt line.

Durable Press Resins in the Textile Industry

The industrial revolution of the late 18th and early 19th centuries began the transformation of the textile industry from laborious hand spinning wool and cotton fabrics to mass production of cellulosic, synthetic and blended fabrics. As new methods for processing and providing unique appearances to fabrics became available, the desire for fashionable fabrics heightened. The first synthetic dye was created by William Henry Perkin in 1856 when he accidentally produced the first aniline purple (mauveine) while trying to make quinine.4 The ability to impart certain performance qualities to fabrics, i.e., better feel and durability, soon became essential as well.
More than 100 years ago (1906), X. Eschalier revitalized the cotton fabric industry when he first discovered that treatment of cellulosic fabrics with formaldehyde improved the strength of the fibers.5,6 The first stiffening agents used consisted of urea-formaldehyde resins later followed by melamine-formaldehyde. These synthetic resins reacted with formaldehyde and formed cross-links with adjacent cellulose fiber molecules. These inexpensive resins offered garments wrinkle resistance and shape retention (they held a crease) following wear and laundering.7 Garments with these qualities are referred to as “durable press” garments.

The Downside of These Resins

Formaldehyde-based resins became widely used as a means to attain low-cost wrinkle resistance. There was a detriment though: Because of the instability of formaldehyde resins, not only was the fabric weakened but it attained a yellow hue when exposed to chlorines. In addition, formaldehyde fumes — up to 12,000 ppm — were released from the garments.5 This formaldehyde release was the cause of significant contact hypersensitivity.8,9

The introduction of synthetic fibers began in 1930 when Wallace Carothers discovered an extraordinarily soft but strong fiber: nylon.10 This new discovery spurred haste in the textile industry to create a finish that imparted strength and durable press to cellulosic fibers. In the 1950s, strong blended man-made fibers were developed that cross-linked cotton and cellulosic polymers (rayon) using cyclic ethylene and propylene urea resins. These resins had a distinct advantage over urea- and melamine-formaldehyde resins in that they were more stable, releasing less formaldehyde and chlorine/wash fast.5 The development of the cyclic urea derivative resin 1,3-bishydroxymethyl-4,5-dihydroxy-2-imidazolidinone in 1961 — better known as dimethyloldihydroxyethylene urea (DMDHEU, Fixapret CPN) — further decreased formaldehyde release to approximately 200 to 300ppm.11,12 However, despite their significantly decreased formaldehyde release, these resins continued to produce contact hypersensitivity.13

Developing Standards for Formaldehyde Release

Within the past decade, Asian and European countries have developed strict standards for formaldehyde release from textile finishes. Once the most widely used durable-press resin, DMDHEU’s use is declining in favor of lower formaldehyde-releasing resins. The law for the Control of Household Products Containing Harmful Substances was enacted in Japan in 1973. This law restricted the amount of formaldehyde allowed in textile articles.

Since the late 1980s, several other countries have also instituted limits on formaldehyde in textiles. In Japan, the current standard level of formaldehyde allowed in products used by children must not exceed 20 ppm. The amount of formaldehyde in textile products for adults must not exceed 75 ppm.14 Oeko-Tex, a European organization that “fosters skin-friendly clothing” and has set limits on certain chemicals that can be found in clothing and other textiles, has adopted the 75 ppm limit. Their tag is a stamp of approval that informs the consumer that the textile does not contain dangerous levels of harmful substances.15

Currently DMDHEU is sparsely used in European countries because of its high free formaldehyde release, as opposed to modified dimethyloldihydroxyethylene urea (DMDHEU, methanol, and diethylene glycol; Fixapret ECO), which is gaining favor.16 Fixapret ECO maintains the same high quality and physical performance while releasing approximately 75 ppm free formaldehyde, which meets Japanese and Oeko-Tex standards. There are some resins that release zero free formaldehyde, including 1,3-dimethyl-4,5-dihydroxyimidazolidione-2 (DMeDHEU, Fixapret NF). But at this time, other than for use in infant fabrics, these resins are not as widely accepted. Their lower level of acceptance stems from the high complexity of production, high cost, and less reactivity (i.e., need to apply more to the fibers). Newly available fiber advancements that impart high strength and performance without chemical additives, such as nano-fibril technology, are increasingly popular overseas.17

When to Suspect Textile Allergy

Accurately determining the percentage of true textile resin allergy is difficult because there have not been studies that measure the rate of textile resin allergy in the general population. Consider ACD in an individual who has longstanding recalcitrant or recurrent dermatitis. The patient’s history as well as area(s) of distribution are essential to determining a contact allergen as the cause of the patient’s dermatitis. With regard to allergic contact dermatitis from clothing resins (and dyes, for that matter), the body regions most commonly involved are areas that come into close direct contact with the skin. These include flexor surfaces (especially the popliteal and antecubital regions), posterior neck, anterior and medial thighs, and waistline. The anterior and posterior axillary folds are also commonly affected with sparing of the axillary vault. (See Figure 1.)18,19


Environmental factors in these areas also play a role in allergic contact dermatitis and include heat, perspiration, pressure, and friction. These factors contribute to formaldehyde release from fabrics and enhance the allergic response.20 Unusual clinical presentations may occur in patients who are allergic to formaldehyde textile resins (FTR) on furniture or bedding, as well as individuals who use products made with formaldehyde-releasing preservatives. The most common formaldehyde releasing preservative that causes ACD is quaternium-15.21

Patch Testing

Patch testing for FTR ACD can be challenging. The 1% aqueous formaldehyde used for patch testing established approximately 70% of those individuals with FTR allergy. In a recent study by Lazarov, patch testing with the formaldehyde releasing preservative quaternium-15 was reported to produce a positive reaction in 9% of patients with concomitant FTR.22 Since the rate of positive patch test results using aqueous formaldehyde is suboptimal in suspected FTR, it is necessary to conduct patch testing using specific FTRs. The six formaldehyde resins that are available for patch testing are listed in Table 2. Of these six formaldehyde resins, ACD is most often diagnosed using ethylene urea, melamineformaldehdye (Fixapret AC) and dimethylol dihyroxyethyleneurea (Fixapret CPN). There have also been positive patch test results to an FTR in the absence of a positive response to aqueous formaldehyde, reinforcing the necessity to patch test using specific FTRs if ACD to formaldehyde resins is suspected.13,23,24


Formaldehyde Resins and ACD

FTRs constitute approximately 1.2% to 6.2% of patch test diagnosed ACD.13,22,25 Free formaldehyde at levels of 500 ppm to 750 ppm is needed to cause an allergic sensitization, and many patients are sensitized at work. For example, it has been shown that FTR dermatitis is very common in machinists who are commonly sensitized to formaldehyde in biocides.13 In a sensitized patient, low levels produced today by textiles made in the United States containing 100 ppm to 200 ppm and even fabrics that meet the Oeko-Tex strict standards of 75 ppm, may elicit ACD.26,27,28

Due to processes involved in producing permanent press fabrics with formaldehyde resins, it may be impossible to completely eliminate free formaldehyde release. The chemical reaction involved in cross-linking cellulose and cellulosic fibers requires a cross-linking agent, a catalyst, and heat. Some of the catalyst used in this process may remain in the fabric, and heat produced by the body may cause release of free formaldehyde. It has also been suggested that some of the formaldehyde resin may not completely cross-link and may degrade when laundered in chemicals such as sodium hypochlorite (bleach).23,29,30

Avoidance and Education

Formaldehyde is encountered in the workplace in textile workers, machinists (biocides in coolants), and the medical field (dialysis machines, plaster dental molds and in clothing such as lab coats, scrubs and masks).24 Workers sensitized to formaldehyde, such as the dialysis technician in our clinical illustration, may then react to FTRs in clothing or personal protective equipment.

In order to avoid ACD to FTRs it is best to avoid permanent press/wrinkle-resistant, color-fast, stain-resistant, blended fabrics, and other clothing treated with formaldehyde-releasing preservatives. (See Table 3.) Clothing that is made with 100% silk, polyester, acrylic, or nylon is recommended.13 Patients should be reminded that increased temperature and sweating as well as tight-fitting clothing may increase release of allergens from clothing. Patients should be encouraged to discard any of the above clothing that may cause ACD, and when purchasing new clothing, to pay particular attention to the composition and how the fabrics are processed on the tag. Patients may be encouraged to buy clothing made in Japan, as well as clothing labeled with the Oeko-Tex tag or from companies that promote no-finish fabrics. The American Contact Dermatitis Society maintains a Web site for members that lists alternatives for allergic patients, including those allergic to FTRs. Patients who are not able to avoid fabrics treated with FTRs should wear undergarments made of the above appropriate fabric that could prevent contact with potential allergens, although this is often insufficient to prevent dermatitis.


Significance of Case Presentation

Our patient’s job as a dialysis technician involved cleaning the dialysis machine with a formaldehyde disinfectant. She also wore a stiff water-impermeable lab coat while at work. We suspected ACD to formaldehyde, and her patch tests were positive for formaldehyde, ethyleneurea formaldehyde resin, and quaternium-15. She was educated appropriately on avoidance of formaldehyde preservatives and FTRs, and she was advised to avoid wearing her lab coat. Our patient attained complete clearance of her dermatitis by complete avoidance of formaldehydecontaining preservatives and not wearing her lab coat.


 

 

 

 


References

1. Saripalli YV, Achen F, Belsito DV. The detection of clinically relevant contact allergens using a standard screening tray of twenty-three allergens. J Am Acad Dermatol. 2003 July;49(1):65-9.
2. Valks R, Conde-Salazar L, Cuevas M. Allergic contact urticaria from natural rubber latex in healthcare and non-healthcare workers. Contact Dermatitis. 2004; 50(4): 222-4.
3. Warshaw E. Latex allergy. Skinmed. 2003 Nov-Dec;2(6):359-66.
4. Mauveine: The First Industrial Organic Fine-Chemical. Available from URL: http://www.ch.ic.ac.uk/motm/perkin.html.
5. Fowler JF. Formaldehyde as a textile allergen. Curr Probl Dermatol. 2003;31:156-65.
6. S. Po_owi_ski. FIBRES & TEXTILES in Eastern Europe. April/June 2004;46:84-85.
7. Durable press. National Historic Chemical Landmarks. Available from URL: http://acswebcontent.acs.org/landmarks/landmarks/cotton/press.html.
8. Hoving G. Free formaldehyde in textiles. Acad Derm Venereol. 1959;39:357.
9. Marcussen PV.Contact dermatitis due to formaldehyde in textiles 1934-1958. Preliminary report. Acta Derm Venereol. 1959;39:348-56.
10. Nylon 1935, in depth. DuPont. Available from URL: http://heritage.dupont.com/touchpoints/
tp_1935-2/depth.shtml.
11. Vail SL, Reinhardt RM. What do formaldehyde tests measure? Text Chem Color. 1981;13:13.
12. Cooke TF, Weigmann L. The chemistry of formaldehyde release from durable-press fabrics. Text Chem Color. 1982;14:25.
13. Carlson RM, Smith MC, Nedorost ST. Diagnosis and treatment of dermatitis due to formaldehyde resins in clothing. Dermatitis. 2004 Dec;15(4):169-75.
14. Limits on formaldehyde in textiles. Organisation for Economic Co-operation and Development (OECD). Available from URL: http://www.oecd.org/home/0,3305,en_2649_201185_1_1_1_1_1,00.html
15. Oeko-tex standard 100. Oeko-tex Institutes. Available from URL: http://www.oeko-tex.com/
OekoTex100_PUBLIC/index.asp?cls=02.
16. Jim Taylor of Lenzing Fibers (personal communication).
17. Tencel fiber story. Lenzing Fibers. Available from URL: http://www.lenzing.com/ fibers/en/textiles/4180.jsp.
18. Sheretz EF. Clothing dermatitis. Practical aspects for the clinician. Am J Contact Dermatitis. 1992;3:55-64.
19. Fowler JF. Formaldehyde as a textile allergen. Curr Probl Dermatol. 2003;31:156-65.
20. Hatch KL, Mailbach HI. Textile chemical finish dermatitis. Contact Dermatitis. 1986;14:1-13.
21. Robertson MH, Storrs FJ. Allergic contact dermatitis in two mechanisms. Arch Dermatol. 1982;118:997-1002.
22. Lazarov A. Textile dermatitis in patients with contact sensitization in Israel: a 4-year prospective study. Eur Acad Dermatol Venereol. 2004 Sep;18(5):531-7.
23. Metzler-Brenckle L, Rietschel RL. Patch testing for permanent-press allergic contact dermatitis. Contact Dermatitis. 2002 Jan;46(1):33-7.
24. Donovan J, Skotnicki-Grant S. Allergic contact dermatitis from formaldehyde textile resins in surgical uniforms and nonwoven textile masks. Dermatitis. 2007;18(1):40-44.
25. Fowler JF, Skinner SM, Belsito DV. Allergic contact dermatitis from resins in permanent press clothing: An underdiagnosed cause of generalized dermatitis. J Am Acad Dermatol. 1992; 27:962-968.
26. Scheman AJ, Carroll PA, Brown KH, Osburn AH. Formaldehyde-related textile allergy: an update. Contact Dermatitis. 1998 Jun;38(6):332-6
27. Berrens L, Young E, Jansen LH. Free formaldehyde in textiles. Br J Dermatol. 1964;76:110-115.
28. Fisher AA, Kanof NB, Biondi EM. Free formaldehyde in textiles and paper. Clinical significance. Arch Dermatol. 1962;86:753-756
29. Storrs FJ. Dermatitis from clothing and shoes. In: Fisher’s Contact Dermatitis, 3rd edition. Philadelphia: Lea & Febiger, 1986:283-337
30. BASF products for resin finishing technical information bulletin, Jan 2000.
31. T.R.U.E. Test. Allerderm. Available from URL: http://www.truetest.com/panelallergens.aspx.
32. Shank, D. Non-formaldehyde wrinkle-free finishing: a commercial update. AATCC Review v. 2 no. 3 (March 2002) p. 29-32.

Skin & Aging - ISSN: 1096-0120 - Volume 16 - Issue 5 - May 2008 - Pages: 14 - 18

Search Skin & Aging ArticlesAcne Article
Our extensive catalog of Skin & Aging journal articles is right at your fingertips!

Skin & Aging Supplements
Not Just Skin Deep: New Concepts & Approaches to Acne & "Actinic Keratosis"

This Supplement includes the proceedings from a Johns Hopkins CME Symposium

Dermatology SupplementsTHE MANY FACES OF ROSACEA
Topical Treatment of Rosacea: A Clinical Update

One out of every 22 people in the United States has rosacea, a chronic, progressive, inflammatory skin condition that causes a variety of facial cutaneous and ocular symptoms. Although rosacea predominantly affects adults between the ages of 30 and 50 years, 3 clinicians routinely treat patients with rosacea well into their 60s, 70s and even 80s.

Download PDF
Dermatology SupplementsCME Critical Reviews of Clinical Data:
Focus on Anti-TNF Agents for the Treatment of Psoriasis

Psoriasis is one of several systemic diseases presenting chiefly with cutaneous symptoms and with the potential to negatively impact the overall health and quality of life of patients.The immediate concern of most patients is likely to be prompt resolution of the skin involvement...

Download PDF and Take the Test Online
Dermatology SupplementsFall Clinical Dermatology 2007

An Update On Advance In Acne And Excerpts From What's New In The Medicine Cabinet

Download PDF
Dermatology SupplementsAcne Case Reports

Articles in this supplement are based on the proceedings from the 13th annual Acne Case Reports Roundtable Meeting.

Download PDF
Dermatology Supplements2007 ADVANCES IN COSMETIC & MEDICAL DERMATOLOGY “MAUI DERM” CONFERENCE

ARTICLES IN THIS SUPPLEMENT ARE BASED ON SELECTED PRESENTATIONS FROM THE ADVANCES IN COSMETIC & MEDICAL DERMATOLOGY “MAUI DERM” 2007 CONFERENCE HELD JANUARY 17-22, 2007, IN MAUI, HAWAII.

Download PDF
Dermatology Supplements July 2007 CME Supplement

Nonmelanoma skin cancer (NMSC) is the most common malignancy, affecting more than 1 million people in the United States alone.

Download PDF
Dermatology Supplements2007 Winter Dermatology Conference Hawaii®

Based on selected presentations from the Winter Dermatology Conference® held in Kohala Coast, Hawaii, January 13-17, 2007.

Download PDF
Dermatology Supplements2006 4th Annual Fall Conference Supplemental Proceedings

Articles in this supplement are based on selected presentations from the SDPA 4th Annual Fall CME Conference held November 8-11, 2006, in San Diego, CA.

Download PDF

About HMP Communications

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC, which also owns the North American Center for Continuing Medical Education (NACCME). NACCME provides a wide array of accredited CME offerings with industry thought leaders participating in roundtable meetings, webcasts, symposia, conferences, seminars, podcasts and satellite programs. Discover more about HMP’s products and services at www.hmpcommunications.com. ©2008 HMP Communications


© 2008 HMP Communications | Contact Us
83 General Warren Blvd, Suite 100 | Malvern, PA 19355